Stock events for CNO Financial Group, Inc. (CNO)
Over the past six months, CNO Financial Group's stock has increased by 7.9% year-to-date, but experienced a slight decrease of 0.36% in the past month as of late October 2025. CNO reported its first-quarter 2025 results with net income declining but net operating income increasing, with annuity collected premiums up 12%, client assets in brokerage and advisory up 16%, health new annualized premiums up 9%, and Medicare Supplement premiums up 24%, returning $116.8 million to shareholders. CNO Financial Group also reported its second-quarter 2025 results and is scheduled to release third-quarter results on November 3, 2025. The company declared a $0.17 quarterly dividend in August 2025. Keefe, Bruyette & Woods maintained a "Market Perform" recommendation for CNO Financial Group in October 2025. CNO Financial Group Inc. acquired a minority stake in private credit manager Victory Park Capital for $600 million in capital commitments in September 2025. Optavise, a CNO brand, partnered with Rula to improve workforce access to mental health services in October 2025.
Demand Seasonality affecting CNO Financial Group, Inc.’s stock price
While specific seasonal patterns for CNO Financial Group's product demand are not explicitly detailed, general trends in the insurance industry can be observed. During the pandemic, there was an uptick in demand for life and health insurance, but consumer focus has since shifted back to traditional concerns about retirement planning and securing health, income, and retirement needs. CNO's products, such as Medicare Supplement insurance, may see increased interest during open enrollment periods.
Overview of CNO Financial Group, Inc.’s business
CNO Financial Group, Inc. is an American financial services holding company that develops, markets, and administers health insurance, annuity, individual life insurance, and other financial services products, primarily serving middle-income pre-retiree and retired Americans. The company's major products and services include health insurance such as Medicare Supplement, long-term care, and critical illness insurance; life insurance including term, whole, and universal life; annuities like fixed indexed and fixed-rate annuities; financial services offering wealth management solutions; and workforce benefits solutions providing voluntary benefits and administration technology. CNO distributes its products through three main operating segments: Bankers Life, Washington National, and Colonial Penn.
CNO’s Geographic footprint
CNO Financial Group is headquartered in Carmel, Indiana, and operates across all fifty states, the District of Columbia, and certain U.S. protectorates. The company maintains a significant market presence in states such as Florida, Iowa, Pennsylvania, California, and Texas, with offices in over 220 communities across the U.S., including corporate offices in Birmingham, Chicago, Orlando, and Milwaukee.
CNO Corporate Image Assessment
CNO Financial Group has cultivated a strong brand reputation, particularly in the area of employee well-being and financial stability. The company has been recognized for building an "award-winning healthy culture" and for excellence in health and well-being. It has been named one of America's Healthiest Workplaces and received a Bell Seal Award for workplace mental health. CNO is rated as investment grade by all four leading ratings agencies: AM Best, Moody's, Fitch, and S&P. AM Best affirmed the Financial Strength Rating of A (Excellent) and the Long-Term Issuer Credit Ratings of "a" (Excellent) for CNO's life/health insurance subsidiaries in February 2024, with a stable outlook.
Ownership
CNO Financial Group's stock is predominantly held by institutional investors, who own approximately 95.4% of the shares, while insiders hold about 3.0% of the shares. Major institutional owners include BlackRock Inc., The Vanguard Group, Inc., and State Street Corp. The largest individual insider shareholder is Roger Keith Long, owning 4.60% of the company's shares.
Ask Our Expert AI Analyst
Price Chart
$39.59